Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inogen Inc Director's Dealing 2014

Oct 22, 2014

33625_dirs_2014-10-21_c14abd79-5e5b-4556-8411-e43b96a17d0b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2014-10-20

Reporting Person: Huggenberger Raymond (Director, President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-10-20 Common Stock M 25722 $0.60 Acquired 32530 Direct
2014-10-20 Common Stock S 25722 $19.8319 Disposed 6808 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-10-20 Stock Option (right to buy) $0.60 M 25722 Disposed 2019-02-10 Common Stock (25722) Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2014.

F2: Represents the weighted average share price of an aggregate total of 25,722 shares sold in the price range of $19.50 to $20.16 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.